Dronabinol for COPD-related breathlessness
Treatments studied
Part of Lungs & breathing, Mental health clinical trials.
This trial tests whether a drug called dronabinol (a synthetic form of THC) can help reduce severe shortness of breath in people with advanced COPD who are already receiving the best available treatment. If you have severe COPD and still feel very breathless, this study may offer a new option to improve your breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have severe or very severe COPD (GOLD stage 3 or 4).
- You must have persistent shortness of breath even though you are on your best treatment (mMRC score ≥ 3).
- You must not have had a COPD flare-up or infection in the last month.
- You must not be using cannabis, THC, or CBD products currently.
- You need to be able to understand and speak Danish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests whether inhaled cannabidiol (CBD) is safe and well-tolerated in healthy people who use cannabis occasionally. You’d be asked to avoid other cannabis and certain drugs around study visits so researchers can measure your response clearly.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This Phase 1 study tests how THC (the main active ingredient in cannabis) affects healthy adults, and whether effects differ by gender. It’s designed to learn about short-term body and brain responses to THC.
This study tests whether dronabinol, a cannabis-like medicine, can help people with moderate sleep apnea breathe better at night. It may be an option for those who haven't found other treatments helpful.
This early-stage study tests whether dronabinol (a form of THC) changes pain perception in people with opioid use disorder who are already stable on methadone or buprenorphine. It may help researchers understand whether this treatment affects pain and drug-related outcomes in a safer, controlled way.
This study tests whether a synthetic form of THC (a compound related to marijuana) can improve sleep in people with sleep apnea who use CPAP. It may help reduce breathing pauses during sleep.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.